PME
Delivery · High$16.9BCF+
Pro Medicus
Medical imaging
Visage Imaging radiology platform — AI-driven workflows used by 50+ major health systems globally
Cash data from Dec 2025 4C(5mo old)Figures from ASX filings · not financial advice
[ VITALS ]
Cash on Hand
$0.0M
Dec 2025 4C
Runway
CF+Cash Flow Positive
Based on Dec 2025 4C
Market Cap
$16.9B
Burn Rate
—
Dec 2025 4C
Shares Outstanding
104M
Pipeline Assets
2
Latest Insightprice-sensitive announcements & broker notes
Price-sensitiveOther5 June 2026
S&P DJI Announces June 2026 Quarterly Rebalance
Pro Medicus Limited (PME) has been removed from the S&P/ASX 50 Index effective June 22, 2026, following the June quarterly rebalance by S&P Dow Jones Indices. ALS Limited (ALQ) will be added to the index in PME's place. This represents a change in PME's index constituents status.
3M Price
PME.ASX$161.580+21.0% 3M
Low $114.600High $165.790
Pipeline Assets (2)
Visage 7Diagnostic imaging platform (radiology PACS)
ApprovedVisage 7 Open ArchiveVendor-neutral image archive
ApprovedDiscovery
Preclinical
Ph 1
Ph 1/2
Ph 2
Ph 2/3
Ph 3
NDA
Capital Raises & Buybacks
4 buybacks
Current shares outstanding: 104M
Buyback
Buyback Detail
2026-04-01on-market
2026-04-01on-market
Other ticker dataInsider activity, holders, grants, publications
expand ›
Insider activity, holders, grants, publications
Director Transactions
1 transactionLast 90dNo Activity
Buys0-1 vs prior
Sells0
$993,812
Catalysts (12)· 6 upcoming · 6 past
FY2026 full-year results
UpcomingConfirmedarrow_upwardHigh19 Aug 2026
First digital pathology client deployment
UpcomingExpectedarrow_upwardHigh30 Sept 2026
Expectedarrow_upwardHigh31 Dec 2026
Track RecordDelivery Consistency Index
expand ›
Delivery Consistency Index
Historical delivery and spending consistency. Data is limited for recently added companies.
Delivery Consistency Index
Delivery
High100/100
Timeline adherence · phase-adjusted tolerance · recency-weighted · min 3 catalysts
Capital discipline
–Insufficient data
1/2 data points needed
Burn rate stability · stage-adjusted thresholds · runway trend · R&D focus
Hit 6 of 6 guided dates· rolling 2yr· of 12 tracked
Filing discipline not scored — this company reports under US regime (Form 10-K / 10-Q). ASX Listing Rule 4.7C deadlines don't apply.
What drove these scores · rolling 2yr
arrow_drop_up
Material revenue step-up in FY27 — Delivered 395d early
·
PME signs 7-Year A$90M Deal with Beth Israel Lahey Health — Delivered on time
·
PME signs 5-year, A$28M contract renewal Allegheny Health — Delivered on time
·
Interview with Dr Sam Hupert - CEO of Pro Medicus Ltd — Delivered on time
·
PME signs 5-year, A$16M contract renewal with OSU — Delivered on time
·
S&P DJI Announces June 2026 Quarterly Rebalance — Delivered on time
Completed catalysts
✓PME signs 7-Year A$90M Deal with Beth Israel Lahey Health— Pro Medicus signed a 7-year, A$90M contract with Beth Israel Lahey Health to implement its cloud-based Visage 7 Enterprise Imaging Platform across 14 hospitals in Massachusetts and New Hampshire. The deal includes full-stack implementation (Viewer, Workflow, and Open Archive) on a transaction-based licensing model with potential upside, with go-live targeted for Q1 2027.
On time
✓PME signs 5-year, A$28M contract renewal Allegheny Health· partnership — counterparty-driven— Pro Medicus renewed a 5-year, A$28M transaction-based contract with Allegheny Health Network for its Visage 7 medical imaging platform, including the addition of Visage 7 Workflow, with increased minimums and an increased fee per transaction.
On time
✓Interview with Dr Sam Hupert - CEO of Pro Medicus Ltd— Pro Medicus CEO discusses three major US healthcare contract wins totaling A$90M (BILH), A$23M (U Maryland), and Tidal Health, plus A$120M in recent renewals. FY26 sales exceed A$400M, representing a record year with unprecedented implementation activity scheduled across H2 FY26 and into FY27, driving material revenue step-up expected in FY27.
On time
✓PME signs 5-year, A$16M contract renewal with OSU· partnership — counterparty-driven— Pro Medicus renewed a 5-year, A$16M transaction-based contract with The Ohio State University Wexner Medical Center for its Visage 7 imaging platform, expanding the agreement to include Visage 7 Workflow and Visage 7 Cardiology Imaging with increased minimums and fees per transaction.
On time
✓S&P DJI Announces June 2026 Quarterly Rebalance— Pro Medicus Limited (PME) has been removed from the S&P/ASX 50 Index effective June 22, 2026, following the June quarterly rebalance by S&P Dow Jones Indices. ALS Limited (ALQ) will be added to the index in PME's place. This represents a change in PME's index constituents status.
On time
✓Material revenue step-up in FY27— Pro Medicus signed a 7-year, A$16M contract with TidalHealth for Visage 7 full-stack imaging platform deployment across TidalHealth's hospital network in the Mid-Atlantic region, representing one of the major US healthcare contracts expected to drive material revenue step-up in FY27.
395d early
Outcome quality (positive/negative readouts) reflects the science, not execution — shown above but excluded from the score.
These metrics reflect historical operational data only. They are not predictive of future performance, do not constitute investment advice, and should not be used as the basis for any investment decision.
Announcements(16)
article
OtherPSauto_awesome
S&P DJI Announces June 2026 Quarterly Rebalance5 June 2026
expand_more125KB
handshake
PartnershipPSauto_awesome
PME signs 5-year, A$16M contract renewal with OSU3 June 2026
expand_more175KB
article
OtherPSauto_awesome
Interview with Dr Sam Hupert - CEO of Pro Medicus Ltd31 May 2026
expand_more379KB
handshake
PartnershipPSauto_awesome
PME signs 5-year, A$28M contract renewal Allegheny Health31 May 2026
expand_more255KB
handshake
PartnershipPSauto_awesome
PME signs 7-year, A$16M contract with TidalHealth31 May 2026
expand_more175KB